|
Faculty, University of Wisconsin School of Medicine and Public Health
George Wilding, MD was named Director of the University of Wisconsin Paul P. Carbone Comprehensive Cancer Center in January 2004. A nationally renowned prostate cancer researcher, Wilding is the Donald and Marilyn Anderson professor of medicine and serves as head of the Medical Oncology section within the Department of Medicine at UW Medical School. He has been a UW Carbone Cancer Center member since joining the UW faculty in 1988.
A native of Everett, Massachusetts, Wilding graduated from the University of Massachusetts Medical School, where he also completed his internship and residency in Internal Medicine. He underwent training in Medical Oncology within the Medicine Branch at the National Cancer Institute. He has a master's degree (pharmacology) from Pennsylvania State University and bachelor's degrees from Tufts University (chemical engineering and biology).
| UW Health Clinics |
|
Medical Oncology Clinic
|
 (608) 265-1700
(800) 323-8942
|
UW Carbone Cancer Center
|
Map
|
Wayfinding
|
|
Urology Cancer Clinic
|
(608) 263-4757
(800) 323-8942
|
UW Carbone Cancer Center
|
Map
|
| Languages Spoken |
|
English
|
|
Medical interpreters are available to help
patients communicate with hospital and clinic staff.
For more information, please contact
interpreter services at (608) 262-9000.
|
|
Professional Certifications and Education
|
| Board Certification |
Internal Medicine
Medical Oncology
|
| Fellowship |
National Cancer Institute, NIH, Bethesda, MD
|
| Residency |
University of Massachusetts Medical School, Worcester
|
| Internship |
University of Massachusetts Medical School, Worcester
|
| Medical School |
University of Massachusetts, Worcester, 1980
|
|
Hospital Affiliations
|
| Primary Affiliation(s) |
University of Wisconsin Hospital and Clinics
|
| Secondary Affiliation(s) |
Veterans Hospital - Wm. S. Middleton Memorial
|
| Research |
In his clinical practice, Wilding sees patients with genitourinary cancers, including prostate, kidney, testicular and bladder cancers. From 1995 to 2003, he directed the UW Carbone Cancer Center Experimental Therapeutics Program, which seeks to identify new anti-cancer agents in the laboratory and translate them into clinical treatments with human patients. He served as chairman of the Genitourinary Cancer Committee of the Eastern Cooperative Oncology Group, a National Cancer Institute (NCI)-sponsored clinical research group for 10 years until 2003, and serves on numerous NCI, industry and foundation advisory and review boards. |
| UW School of Medicine and Public Health |
| Medicine |
|
